Both the European EMA and the American FDA certificate make it possible to introduce Polpharma Biologics drugs to markets in Europe and the United States. You will be able to hear, among other things, what this means for an enterprise such as Polpharma Biologics on December 7, 2023, in the Gdańsk Science and Technology Park, during the fifth edition of the BioTech Daily conference. The unique program of this year’s edition will include inspiring lectures given by top-class experts from Tricity biotechnology companies, including Polpharma Biologics, QIAGEN and the Healthcare department of Kainos, as well as scientists from the Medical University of Gdańsk.

Additionally, the event will feature the final gala of the Life Science Acceleration Zone Program organized by the Pomeranian Special Economic Zone in strategic partnership with Polpharma Biologics. Young, promising companies and design groups will have the opportunity to present their projects to the public and specialists. This is a special time when startups’ presentations and innovations will be subject to detailed analysis by experts. Demo Day is not only an opportunity to honor entrepreneurs for their hard work and commitment, but also a great opportunity to inspire others who also dream of breakthroughs in biotechnology, medicine and science. The event will culminate in the presentation of awards to the program winners.